ROBO Global®
Healthcare Technology and Innovation ETF
Schedule of Investments
January 31, 2024 (Unaudited)
| Description | Shares | Fair Value | ||||||
| COMMON STOCK — 99.8% | ||||||||
| China — 0.9% | ||||||||
| Consumer Staples — 0.9% | ||||||||
| JD Health International * | 168,550 | $ | 551,969 | |||||
| Total China | 551,969 | |||||||
| France — 1.5% | ||||||||
| Health Care — 1.5% | ||||||||
| Eurofins Scientific | 15,082 | 919,075 | ||||||
| Total France | 919,075 | |||||||
| Germany — 1.5% | ||||||||
| Health Care — 1.5% | ||||||||
| Siemens Healthineers | 16,812 | 947,067 | ||||||
| Total Germany | 947,067 | |||||||
| Italy — 1.7% | ||||||||
| Health Care — 1.7% | ||||||||
| DiaSorin | 11,071 | 1,028,691 | ||||||
| Total Italy | 1,028,691 | |||||||
| Japan — 1.0% | ||||||||
| Health Care — 1.0% | ||||||||
| Terumo | 18,700 | 643,610 | ||||||
| Total Japan | 643,610 | |||||||
| Netherlands — 1.6% | ||||||||
| Health Care — 1.6% | ||||||||
| Koninklijke Philips * | 47,303 | 1,016,146 | ||||||
| Total Netherlands | 1,016,146 | |||||||
| Switzerland — 3.5% | ||||||||
| Health Care — 3.5% | ||||||||
| Lonza Group | 2,368 | 1,172,613 | ||||||
| Tecan Group | 2,558 | 991,771 | ||||||
| Total Health Care | 2,164,384 | |||||||
| Total Switzerland | 2,164,384 | |||||||
| United Kingdom — 1.2% | ||||||||
| Health Care — 1.2% | ||||||||
| Smith & Nephew PLC | 53,932 | 762,687 | ||||||
| Total United Kingdom | 762,687 | |||||||
| United States — 86.9% | ||||||||
| Health Care — 84.8% | ||||||||
| Abbott Laboratories | 8,115 | 918,212 | ||||||
| Agilent Technologies | 6,910 | 898,991 | ||||||
| Align Technology * | 3,733 | 997,906 | ||||||
| Alnylam Pharmaceuticals * | 3,006 | 519,767 | ||||||
| Arrowhead Pharmaceuticals * | 41,046 | 1,317,578 | ||||||
| Artivion * | 48,055 | 803,480 | ||||||
| Description | Shares | Fair Value | ||||||
| Avanos Medical * | 23,813 | $ | 456,971 | |||||
| Axogen * | 74,925 | 724,525 | ||||||
| Azenta * | 20,760 | 1,353,551 | ||||||
| Baxter International | 16,880 | 653,087 | ||||||
| Becton Dickinson | 3,153 | 752,968 | ||||||
| BioMarin Pharmaceutical * | 7,713 | 679,361 | ||||||
| Bio-Rad Laboratories, Cl A * | 2,485 | 797,412 | ||||||
| Boston Scientific * | 17,955 | 1,135,833 | ||||||
| Bristol-Myers Squibb | 15,164 | 741,065 | ||||||
| CareDx * | 93,844 | 803,305 | ||||||
| Catalent * | 23,871 | 1,232,698 | ||||||
| Charles River Laboratories International * | 5,128 | 1,109,084 | ||||||
| CONMED | 5,877 | 561,841 | ||||||
| Danaher | 4,518 | 1,083,913 | ||||||
| DexCom * | 8,920 | 1,082,442 | ||||||
| Edwards Lifesciences * | 13,105 | 1,028,349 | ||||||
| Exact Sciences * | 11,723 | 766,684 | ||||||
| Fulgent Genetics * | 34,779 | 855,216 | ||||||
| GE HealthCare Technologies | 11,634 | 853,470 | ||||||
| Globus Medical, Cl A * | 8,827 | 465,977 | ||||||
| Guardant Health * | 35,368 | 775,620 | ||||||
| Health Catalyst * | 69,878 | 682,708 | ||||||
| Hologic * | 12,021 | 894,843 | ||||||
| Illumina * | 9,020 | 1,289,950 | ||||||
| Incyte * | 16,422 | 965,121 | ||||||
| Insulet * | 5,381 | 1,027,071 | ||||||
| Integra LifeSciences Holdings * | 24,876 | 998,771 | ||||||
| Intuitive Surgical * | 3,279 | 1,240,184 | ||||||
| IQVIA Holdings * | 4,450 | 926,624 | ||||||
| iRhythm Technologies * | 10,856 | 1,300,333 | ||||||
| Masimo * | 7,284 | 939,199 | ||||||
| Medpace Holdings * | 2,917 | 850,539 | ||||||
| Moderna * | 12,463 | 1,259,386 | ||||||
| Natera * | 16,861 | 1,111,814 | ||||||
| Novocure * | 69,199 | 963,250 | ||||||
| Omnicell * | 27,057 | 870,424 | ||||||
| Penumbra * | 4,333 | 1,092,739 | ||||||
| Privia Health Group * | 30,962 | 624,194 | ||||||
| QIAGEN | 24,213 | 1,057,146 | ||||||
| QuidelOrtho * | 11,869 | 813,145 | ||||||
| Regeneron Pharmaceuticals * | 1,186 | 1,118,137 | ||||||
| Revvity | 11,081 | 1,187,662 | ||||||
| Roche Holding | 2,484 | 715,506 | ||||||
| STAAR Surgical * | 29,849 | 836,070 | ||||||
| Stryker | 3,478 | 1,166,800 | ||||||
| Teladoc Health * | 29,698 | 577,032 | ||||||
| Thermo Fisher Scientific | 2,092 | 1,127,546 | ||||||
| Twist Bioscience * | 31,487 | 1,020,179 | ||||||
| Veeva Systems, Cl A * | 4,251 | 881,700 | ||||||
| Veracyte * | 29,611 | 740,867 | ||||||
| Vertex Pharmaceuticals * | 2,366 | 1,025,377 | ||||||
| 52,673,623 | ||||||||
| Information Technology — 1.3% | ||||||||
| Novanta * | 5,223 | 807,215 | ||||||
| 807,215 | ||||||||
ROBO Global®
Healthcare Technology and Innovation ETF
Schedule of Investments
January 31, 2024 (Unaudited)
| Description | Shares | Fair Value | ||||||
| Materials — 0.8% | ||||||||
| Ginkgo Bioworks Holdings * | 408,258 | $ | 493,992 | |||||
| 493,992 | ||||||||
| Total United States | 53,974,830 | |||||||
| Total Common Stock | ||||||||
| (Cost $81,455,829) | 62,008,459 | |||||||
| SHORT-TERM INVESTMENT — 0.1% | ||||||||
| Invesco Government & Agency Portfolio, Institutional Class, 5.24%(A) | 38,776 | 38,776 | ||||||
| Total Short-Term Investment | ||||||||
| (Cost $38,776) | 38,776 | |||||||
| Total Investments - 99.9% | ||||||||
| (Cost $81,494,605) | $ | 62,047,235 | ||||||
Percentages based on Net Assets of $62,080,973.
| * | Non-income producing security. |
| (A) | Rate shown is the 7-day effective yield as of January 31, 2024. |
Cl - Class
PLC - Public Limited Company
ROB-QH-001-2100